US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Nigeria Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... of challenges that have previouslyled to delays in its implementation. The eventual rollout of the act will make Nigeria an attractive prospectfor multinational drugmakers over the long-term, though political and fiscal barriers limit the successfullikelihood ...  |  read more...
USD 1,295
Emerging Pharmaceuticals Industry Forecasts - China Focus
4/1/2016 | published by: Asia Market Information & Development Company
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ...  |  read more...
USD 1,000
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... through improvements to the domestic pharmaceutical industry. In turn, this will reduce its reliance on imported medicines; however, the basic capabilities of local drugmakers will make it difficult to achieve self-sufficiency in the near future, ...  |  read more...
USD 1,295
Tanzania Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... to improve the situation and is implementing certain strategies to this end, the large funding gap and pre-existing structural issues will continue to hinder patients' access to essential medicines. We highlight, however, that access to ...  |  read more...
USD 1,295
Turkey Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... commercial opportunities for pharmaceutical manufacturers. Despite this positive development, cost containment measures will remain a risk, as will the political situation with neighbouring Syria and nearby Russia. Headline Expenditure Projections Pharmaceuticals: TRY20.81bn (USD7.64bn) in 2015 ...  |  read more...
USD 1,295
Hong Kong Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... rising medical costs as chronic diseases rise and tax revenues decline due to the rising dependency ratio. Similarly, healthcare delivery will be a key area of focus as the special administrative region augments the existing ...  |  read more...
USD 1,295
Mexico Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... The market size combined with an improving business environment makes the country an attractive prospect for foreign drugmakers Headline Expenditure Projections Pharmaceuticals: MXN177.3bn (USD11.2bn) in 2015 to MXN182.8bn (USD10.3bn) in 2016; +3.1% in local currency ...  |  read more...
USD 1,295
Portugal Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... for drugmakers is expected to continue over the coming years, as illustrated by recent government commitments to sustain a more balanced approach in terms of ensuring sustainable access to heath, as well as promoting competitiveness ...  |  read more...
USD 1,295
South Africa Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... supported through a variety of other driving factors including cost-containment measures and revised pricing structures. Despite the South African Department of Health's commitment to improving regulatory conditions, issues relating to consumer perceptions are set to ...  |  read more...
USD 1,295
Uganda Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... to improve the situation and is implementing certain strategies to address this, health sector inefficiencies persist and there is an absence of a sustainable, long-term plan. For Uganda, meeting treatment targets, such as the UNAIDS ...  |  read more...
USD 1,295
Ukraine Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... to the country's poor epidemiological profile. The country's pharmaceutical market will maintain strength as sluggish domestic production combined with robust and rising medical demand results in an even higher reliance on foreign healthcare investors and ...  |  read more...
USD 1,295
Uzbekistan Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... its relatively poor prognosis for infectious diseases control. Pharmaceutical companies with drug portfolios addressing both infectious diseases and chronic diseases will see commercial opportunities arise in Uzbekistan. However, we expect that this will be moderated ...  |  read more...
USD 1,295
Venezuela Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... government in the future. The costs of such deals have been long expected and will be unlikely to be more damaging. Foreign currency controls, drug price controls, currency devaluation and delayed debt payments will continue ...  |  read more...
USD 1,295
Philippines Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... demand for healthcare services and medicines. Access to medicines will be strengthened by the continued expansion of universal healthcare in the country. However, price caps on high-value medicines and poor intellectual property protection continue to ...  |  read more...
USD 1,295
Global Constipation Market Report: 2016 Edition
4/1/2016 | published by: Koncept Analytics
... significant, even deliberating effect on the quality of life of a patient. Various treatment options are available for the treatment of constipation and patients often adopt different over-the-counter remedies for the same. There exist three ...  |  read more...
USD 800
Pharmacies in Australia - Industry Market Research Report
4/4/2016 | published by: IBISWorld
... pharmacy groups include independent community pharmacies, banner groups (both wholesaler-owned and independent), friendly societies, buying groups and discount pharmacies. This report covers the scope, size, disposition and growth of the industry including the key sensitivities ...  |  read more...
USD 965
2016 U.S. Pharmaceutical Preparation Mfg.. Industry-Accounting & Auditing Report
4/5/2016 | published by: Barnes Reports
... report features 2016 estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry ...  |  read more...
USD 299
Jordan Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... instabilities within the region. The government remains committed to healthcare modernisationand expansion, and as austerity measures are relaxed, we expect this will help drive medicine uptake andconsumption for the Jordanian population. However, the healthcare system ...  |  read more...
USD 1,295
Namibia Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... of medicine production. However, this is unlikely to be achieved in the foreseeable future given thelimited production capacity among domestic companies including Fabupharm. Headline Expenditure Forecasts Pharmaceuticals: NAD2.34bn (USD184mn) in 2015 to NAD2.56bn (USD172mn) in ...  |  read more...
USD 1,295
Romania Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... However, aggressive drug pricing regulations, including the imminent joint drugprocurement agreement with Bulgaria will limit revenue earning opportunities. Headline Expenditure Projections Pharmaceuticals: RON14.94bn (USD3.73bn) in 2015 to RON16.16bn (USD3.91bn) in 2016; 8.2% inlocal currency terms ...  |  read more...
USD 1,295
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2016
3/23/2016 | published by: BMI Research
... localpharmaceutical companies will be further assisted as the government aims to use the policy to reducemedicine imports. We highlight that these changes will come at the expense of drugmakers in India andBangladesh, which have been ...  |  read more...
USD 1,295
2016 U.S. Pharmaceutical Preparation Mfg.. Industry-Consulting and Management Report
3/25/2016 | published by: Barnes Reports
... report features 2016 estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, payroll, industry ...  |  read more...
USD 299
Serbia Pharmaceuticals and Healthcare Report Q2 2016
4/1/2016 | published by: BMI Research
... drug price cuts by the RFZO, will dampen growth. Furthermore, an increasing reliance on private health spending will impact pharmaceutical sales as the worsening macroeconomic outlook will reduce consumer spending power. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... and healthcare suppliers. However, inefficiencies and debt within healthcare provision will fuel instability in the healthcare sector. Headline Expenditure Projections Pharmaceuticals: COP9,101bn (USD3.31bn) in 2015 to COP9,584bn (USD2.92bn) in 2016; +5.3% in local currency and ...  |  read more...
USD 1,295
Norway Pharmaceuticals and Healthcare Report Q2 2016
4/6/2016 | published by: BMI Research
... account for the largest share of healthcare spending over the forecast period. However, the rise in the uptake of employersponsored private health insurance by will continue to promote customised health insurance to reduce absenteeism, which ...  |  read more...
USD 1,295
  2    4  5  6  7  8  9  10